Latest Myriad Genetics News & Updates

See the latest news and media coverage for Myriad. We track all announcements, press releases, and industry mentions in real time, all in one place.

Myriad Genetics (Myriad)

Genetic testing and genomic profiling company

myriad.com

Headquarters: Salt Lake City, United States
Founded year: 1991
Company type: Public company
Number of employees: 2,900–5,000
Industry: Biotechnology & Medical Research

Last updated October 20

Latest news about Myriad Genetics (Myriad)

In short: Myriad Genetics sold its prenatal unit to Labcorp for $210 million and cut 2026 revenue guidance.

Company announcements

October 20 Myriad

Myriad sells prenatal testing business to Labcorp for $210 million

The cash transaction includes inventory value and is expected to close by early 2027, subject to regulatory clearance and customary closing conditions.

September 16 Myriad

Myriad appoints Vishal Sikri as Executive Vice President - Commercial

Sikri succeeds departing Brian Donnelly. Myriad also reaffirms its full-year 2026 financial guidance during this announcement.

July 30 Myriad

Myriad Genetics reports second quarter 2026 financial results

Revenue fell 11% year-over-year to $190.7 million, with initiatives to improve efficiency and scalability.

May 5 Myriad

Myriad Genetics reports first quarter 2026 financial results

Revenue grew 2% to $200.4 million, net loss was $34.1 million, and full-year guidance was reiterated.

Media coverage

October 19 The Globe and Mail

Myriad Genetics to Divest Prenatal Testing Business

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

September 25 Benzinga

Why Is Myriad Genetics Stock Trading Higher Today? - Myriad Genetics (NASDAQ:MYGN)

Labcorp will purchase Myriad Genetics' prenatal testing business for $210 million in cash,...

September 18 Ad Hoc News

Myriad Genetics stock falls after guidance reset and weak Q2 figures

As summarized by Zacks on September 20, 2026, the Zacks Consensus Estimate for the current quarter points to a loss of USD 0.16 per share...

August 24 Yahoo Finance

Myriad Genetics and Moderna Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after shares across biotech and big pharma cooled...

Never miss news about Myriad

Track Myriad and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Myriad competitors & trending companies

Browse news for competitors to Myriad and other trending companies.